Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Healios Revenue (Quarterly): 0.0474M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.0474M |
September 30, 2023 | 0.0485M |
June 30, 2023 | 0.7288M |
March 31, 2023 | 0.053M |
December 31, 2022 | 0.4256M |
September 30, 2022 | 0.0579M |
June 30, 2022 | 0.0849M |
March 31, 2022 | 0.0947M |
December 31, 2021 | 0.0968M |
September 30, 2021 | 0.0999M |
June 30, 2021 | 0.0914M |
March 31, 2021 | 0.085M |
December 31, 2020 | 0.0574M |
September 30, 2020 | 0.066M |
June 30, 2020 | 0.065M |
March 31, 2020 | 0.0643M |
December 31, 2019 | 0.0644M |
September 30, 2019 | 0.0653M |
Date | Value |
---|---|
June 30, 2019 | -0.3093M |
March 31, 2019 | 0.9898M |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | 0.063M |
March 31, 2017 | 0.1759M |
December 31, 2016 | 0.1826M |
September 30, 2016 | 0.1548M |
June 30, 2016 | 0.1963M |
March 31, 2016 | 0.1793M |
December 31, 2015 | 0.1797M |
September 30, 2015 | 0.1408M |
June 30, 2015 | 0.3235M |
March 31, 2015 | 0.1669M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.3093M
Minimum
Jun 2019
0.7288M
Maximum
Jun 2023
0.1046M
Average
0.0653M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 7.081B |
Nxera Pharma Co Ltd | 31.07M |
PeptiDream Inc | 41.78M |
AnGes Inc | 0.3408M |
SanBio Co Ltd | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -11.72M |
Total Expenses (Quarterly) | 7.369M |
EPS Diluted (Quarterly) | -0.1655 |
Enterprise Value | 73.17M |
Profit Margin (Quarterly) | -24.73K% |
Earnings Yield | -40.02% |
Normalized Earnings Yield | -40.02 |